Company:  GILEAD SCIENCES INC (GILD)
Form Type:  4
Filing Date:  8/13/2019 
CIK:  0000882095 
Address:  333 LAKESIDE DR 
City, State, Zip:  FOSTER CITY, California 94404 
Telephone:  (650) 574-3000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$65.30  
Change: 
0.79 (1.23%)  
Trade Time: 
Oct 15  
Market Cap: 
$82.70B
Trade GILD now with 

© 2019  
Description of Business
Gilead Sciences, Inc. (Gilead, we, our or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. We have operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead's primary areas of focus include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. We seek to add to our existing portfolio of products through our internal discovery and clinical development programs, product acquisition, in-licensing and strategic collaborations. 2018 Highlights 2018 was marked by operational excellence and transition as we positioned ourselves for the future growth of our business.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES